P3 Health Partners (PIII) had the highest return between March 7, 2023 and June 20, 2023 by a mid-cap US stock, returning 292.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
P3 Health Partners (PIII) | 3/7/2023 - 6/20/2023 | 292.52% |
D-Wave Quantum (QBTS) | 3/7/2023 - 6/20/2023 | 141.56% |
Soleno Therapeutics (SLNO) | 3/7/2023 - 6/20/2023 | 121.27% |
Xp (XP) | 3/7/2023 - 6/20/2023 | 98.99% |
Dream Finders Homes (DFH) | 3/7/2023 - 6/20/2023 | 96.65% |
SkyWest (SKYW) | 3/7/2023 - 6/20/2023 | 94.61% |
Lifestance Health (LFST) | 3/7/2023 - 6/20/2023 | 91.29% |
Viking Therapeutics (VKTX) | 3/7/2023 - 6/20/2023 | 89.65% |
IONQ (IONQ) | 3/7/2023 - 6/20/2023 | 87.7% |
Oscar Health (OSCR) | 3/7/2023 - 6/20/2023 | 87.32% |
Upstart Holdings (UPST) | 3/7/2023 - 6/20/2023 | 83.97% |
Credo Technology (CRDO) | 3/7/2023 - 6/20/2023 | 83.55% |
CleanSpark (CLSK) | 3/7/2023 - 6/20/2023 | 77.82% |
Riot Blockchain (RIOT) | 3/7/2023 - 6/20/2023 | 77.73% |
Joby Aviation (JOBY) | 3/7/2023 - 6/20/2023 | 71.19% |
Green Brick Partners (GRBK) | 3/7/2023 - 6/20/2023 | 69.25% |
Biohaven Pharmaceutical (BHVN) | 3/7/2023 - 6/20/2023 | 67.75% |
SS Innovations International Inc Common Stock (SSII) | 3/7/2023 - 6/20/2023 | 63.04% |
Krystal Biotech (KRYS) | 3/7/2023 - 6/20/2023 | 62.29% |
Inter & Co Inc Class A Common Shares (INTR) | 3/7/2023 - 6/20/2023 | 62.14% |
Burford Capital (BUR) | 3/7/2023 - 6/20/2023 | 60.52% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 3/7/2023 - 6/20/2023 | 59.46% |
Celsius (CELH) | 3/7/2023 - 6/20/2023 | 59.35% |
Protagonist Therapeutics (PTGX) | 3/7/2023 - 6/20/2023 | 59.05% |
Arlington Asset Investment (AI) | 3/7/2023 - 6/20/2023 | 58.96% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
